Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is showing a bit of weakness in the early session on Thursday. The stock has been nice uptrend over the past month with a jump of 24%.
Tonix Pharmaceuticals to Participate in BIO Digital Conference
announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will participate in the BIO Digital Conference being held June 10-11 and 14-18, 2021.
The Company’s presentation will be made through the BIO Digital Conference website and available on demand to registered participants during the conference at https://www.bio.org/events/bio-digital/sessions?sessionTypes=25903. Following the conference, the presentation will be available under the IR Events tab of the Investors section of the Tonix website at www.tonixpharma.com.
As of 11:06, TNXP stock fell by 1.92% to $1.275 with more than 4.48 million shares traded hands, compared to its average volume of 13.45 million shares. The stock has moved within a range of $ 1.2600 – 1.3400 after opening the trade at $1.28.
|CCI20||111.0022||Buy||Chaikin Money Flow||0.0355||Neutral|
|MACD||0.0596||Buy||Money Flow Index||65.6866||Buy|
|STOCH (14,3)||63.6364||Sell||STOCH RSI||0.0000||OverSold|